A University of Delaware researcher recently received a grant from the National Institutes of Health to develop a new way to examine how cancer cells metastasize. Metastasis is responsible for 90 percent of cancer-related deaths.
Dr. Amanda Paulovich of Fred Hutch will lead a multi-institution effort to develop a biological test to predict which treatments will work for patients with ovarian cancer. Photos, video available: http://www.fredhutch.org/en/news/media-relations/bios-photos/paulovich-amanda/photos-graphics-video.html
Acupuncture, alone or with the medication clomiphene, does not appear to be effective in treating infertility in women with polycystic ovary syndrome (PCOS), according to a new international study including Penn State College of Medicine.
Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to predict who will respond to standard therapies and adverse events leading to therapy discontinuation. A study at The University of Texas MD Anderson Cancer Center revealed new information about how the biomarkers retinoblastoma protein (Rb) and cytoplasmic cyclin E could indicate which patients will respond best to current first-line therapies.
The first three months of sobriety pose the greatest risk for relapse, and the greatest challenge for intervention efforts. Results from a pilot study suggest that a lifestyle physical activity intervention supported by a Fitbit device can successfully supplement existing alcohol treatment among depressed women during early recovery. These results will be shared at the 40th annual scientific meeting of the Research Society on Alcoholism (RSA) in Denver June 24-28.
This webinar will provide a forum to highlight the results of current WIC breastfeeding efforts and to discuss innovative strategies between WIC and other community agencies to promote, protect and support breastfeeding.
A Loyola University Chicago study published this month has found an increase in the percentage of breast cancer patients who were diagnosed in early Stage 1, after the Affordable Care Act took effect. The increases in Stage 1 diagnoses were higher among African American and Latina breast cancer patients.
Women and their physicians are largely uneducated when it comes to females and heart disease, putting women’s health and lives at greater risk, a new study out today shows. The study, published in the Journal of the American College of Cardiology, shows that 45 percent of U.S. women are not aware that heart disease is the No. 1 killer of women.
Scientists from the University of Birmingham have discovered the link between increased male hormones and metabolic complications such as diabetes and fatty liver disease in patients with polycystic ovary syndrome (PCOS).
Women who receive human papillomavirus (HPV) testing, in addition to a pap smear, receive a faster, more complete diagnosis of possible cervical precancer, according to a study of over 450,000 women by Queen Mary University of London (QMUL) and the University of New Mexico (UNM) Comprehensive Cancer Center.
A Texas 1115 Medicaid family planning demonstration proposal that would tie coverage to an exclusion of Planned Parenthood would severely constrain access for covered women, thereby defeating, rather than advancing, Medicaid’s core objectives.
HIV-positive women with CMV in their urine at the time of labor and delivery are more than five times likelier than HIV-positive women without CMV to transmit HIV to their infants. The research also found that they are nearly 30 times likelier to transmit CMV to their infants.
USC Norris Comprehensive Cancer Center is actively recruiting for a clinical trial that seeks to eliminate unnecessary testing for breast cancer with a simple breath test.
Johns Hopkins researchers report that a molecular diagnostic test accurately distinguishes among the three most common causes of vaginitis, an inflammation of vaginal tissue they say accounts for millions of visits to medical clinics and offices in the U.S. each year.
An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children’s Hospital Oakland Research Institute, has identified a possible link between type I interferons and a natural improvement of rheumatoid arthritis (RA) during pregnancy. These findings could have significant implications in the development of safer therapies for RA. This study entitled, “Pregnancy-induced gene expression changes in vivo among women with rheumatoid arthritis: a pilot study,” was published in Arthritis Research & Therapy.
As published in JNCCN, a Siteman Cancer Center study uncovered potential to significantly improve NCCN Guidelines-concordant care in patients with early-stage breast cancer.
Female chronic pain sufferers who catastrophize, a psychological condition in which pain is exaggerated or irrationally focused on, not only report greater pain intensity, but are more likely to be taking prescribed opioids than men with the same condition, according to a study published Online First in Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists (ASA).
Most UTIs are caused by E. coli that live in the gut and spread to the urinary tract. A new study from Washington University School of Medicine in St. Louis has found that a molecular decoy can reduce the numbers of UTI-causing bacteria in the gut, potentially reducing the risk of recurrent UTI.
Can use of hair products have an impact on breast cancer risk for women? That is a question explored by investigators from Rutgers Cancer Institute of New Jersey, Rutgers School of Public Health and other colleagues who examined use of hair dyes, hair relaxers and cholesterol-based hair products in African-American and Caucasian women.
In a study of predominantly African-American women — who have a much higher rate of delivering babies early compared with other racial groups — researchers at Washington University School of Medicine in St. Louis showed that a decrease in the diversity of vaginal microbes of pregnant women between the first and second trimesters is associated with preterm birth.
Zika viral load and the degree of Zika symptoms during pregnancy are not necessarily associated with problems during pregnancy or fetal abnormalities at birth. The presence of antibodies to previously acquired dengue fever also is not necessarily linked to abnormalities during pregnancy or at birth.
Researchers at the University of North Carolina School of Medicine announced the publication of results from a multi-site phase 2 clinical trial with brexanolone, an investigational medication, in the treatment of severe postpartum depression (PPD).
University of Colorado Cancer Center study pinpoints promising link in the chain of hedgehog signaling that, when broken, could reduce the metastatic potential of breast cancer.
Grateful for the life-saving care they received at Loyola Medicine, Peter and Heidi Huizenga have made a generous gift to further oncology research and to honor Kathy Albain, MD, FACP, FASCO.
Abortion fund recipients who have to travel out of state for an abortion travel roughly 10 times farther for their procedures than patients able to get care in their homes states.
Many cultures traditionally use herbs believed to increase milk supply – so called galactagogues – although scientific data are lacking. Now Whitehead Institute Member Jing-Ke Weng and the Family Larsson-Rosenquist Foundation are teaming up to explore the effects of galactagogues on milk production.
An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are inherently slow growing, according to Yale Cancer Center experts.
Lannin and Wang, published June 8 in the New England Journal of Medicine, showed that younger women of screening age are more likely to develop aggressive breast cancers than older women. This added risk reinforces why women should start annual mammography screening at age 40.
A 10-year study, led by Vanderbilt University Medical Center professor of Obstetrics and Gynecology Katherine Hartmann, M.D., Ph.D., disrupts conventional wisdom that uterine fibroids cause miscarriages.
Florida State researchers find women are more likely to pay attention to and remember average and plus-size models in the media compared to thin models.
ROCHESTER, Minn. —Mayo Clinic researchers report that women who suffered adverse childhood experiences or abuse as an adult are 62 percent more likely to have their ovaries removed before age 46. These removals are for reasons other than the presence of ovarian cancer or a high genetic risk of developing cancer, says the new study published today in BMJ Open.
In a controversial study published in Diseases of the Colon and Rectum, researchers from Ankara University, Turkey, found that hysterectomy had an increased negative impact on women, including constipation and incontinence. In an accompanying rebuttal from the University of Wisconsin-Madison, Department of Gynecology, the question of whether hysterectomy does more harm than good is examined.
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
Dr. Kunle Odunsi of Roswell Park Cancer Institute presented an update about an ongoing clinical trial involving T-cell engineering to treat advanced ovarian cancer at the ASCO Annual Meeting in Chicago.
Researchers at Memorial Sloan Kettering Cancer Center in New York have discovered that bacteria living in the gut provide a first line of defense against severe Listeria infections. The study, which will be published June 6 in The Journal of Experimental Medicine, suggests that providing these bacteria in the form of probiotics could protect individuals who are particularly susceptible to Listeria, including pregnant women and cancer patients undergoing chemotherapy.
Six years ago an international team of physician scientists known as BRCA-TAC led a charge to advance clinical testing of the PARP inhibitor olaparib in cancer patients with known inherited mutations in BRCA1 and BRCA2. This weekend during the plenary session of the American Society of Clinical Oncology Annual Meeting (abstract LBA4), that push comes full circle with the presentation of results of the phase III OlympiAD trial demonstrating for the first time that olaparib is superior to chemotherapy in patients with BRCA-related advanced breast cancer.
The study looked at the microbial population in the gastrointestinal tract of infants at a formative stage of life when metabolic set points are being established. The study analyzed the stool samples from 173 white Caucasian and 182 South Asian one-year-olds recruited from two birth cohort studies (CHILD and START).
A genetic test that helps doctors determine how best to treat breast cancer—and whether chemotherapy is likely to help—is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.
For more than two months, Kim O’Neill, 61, spent nearly every night lying in bed, staring at the ceiling and wondering if she was going to die in her sleep. Her heart was beating so loudly in her chest she thought it might explode. During the day, she would struggle to walk up a flight of stairs to the second floor of her home and would run out of breath in the middle of a conversation with her husband. A typically active and positive person, O’Neill was terrified that this was her new normal.
Everything changed in December 2016 when she met Ramesh Hariharan, M.D., a cardiac electrophysiologist with McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann The Woodlands Hospital.
A new study of non-diabetic women with ovarian cancer reveals a potential correlation and area for further study regarding the expression of the GLUT1 glucose transporter receptor at the cancer tissue level. GLUT1 is a receptor protein involved in the absorption of glucose, or sugar, in the bloodstream and across membranes in the body.
Researchers at Columbia University found that women with preeclampsia have a higher stroke risk during pregnancy and postpartum if they have urinary tract infections, chronic high blood pressure, or blood disorders.